| Followers | 35 |
| Posts | 1912 |
| Boards Moderated | 0 |
| Alias Born | 11/05/2020 |
Monday, May 04, 2026 12:40:12 PM
Tough question indeed.
On the one hand we have an 80 something year old CEO who has zero experience in the medical field of this nature trying to get a device approved and on the other hand we have "shareholders" with their excuses and goalpost moving.
At the end of the day though, if this "revolutionary" gel was just that it would have been developed a long time ago. It's as simple as that.
It was created in 1998. Sat dormant for 13 years then "licensed" to a worthless OTC shell in 2012. That same year Fisher claimed they were testing rabbits. Yet, only publishes the paper on the study in 2021 when the FDA requested it. Then when they denied that research paper and asked for a SECOND study it wasn't completed in its entirety.
Are people saying Fisher couldn't "license" this medical device to no other large biotech or pharmaceutical with extensive funds and expertise if it was such a "promising" gel? It could only be licensed to an OTC ticker with no funds, expertise, or real management?
Sure, that doesn't sound too off!
On the one hand we have an 80 something year old CEO who has zero experience in the medical field of this nature trying to get a device approved and on the other hand we have "shareholders" with their excuses and goalpost moving.
At the end of the day though, if this "revolutionary" gel was just that it would have been developed a long time ago. It's as simple as that.
It was created in 1998. Sat dormant for 13 years then "licensed" to a worthless OTC shell in 2012. That same year Fisher claimed they were testing rabbits. Yet, only publishes the paper on the study in 2021 when the FDA requested it. Then when they denied that research paper and asked for a SECOND study it wasn't completed in its entirety.
Are people saying Fisher couldn't "license" this medical device to no other large biotech or pharmaceutical with extensive funds and expertise if it was such a "promising" gel? It could only be licensed to an OTC ticker with no funds, expertise, or real management?
Sure, that doesn't sound too off!
Recent RDGL News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/28/2026 08:44:48 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/06/2026 05:15:04 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 03/04/2026 04:48:52 PM
- Vivos Inc. Diversifies Manufacturing Base with Planned U.S. and International Production Sites • GlobeNewswire Inc. • 02/17/2026 01:30:00 PM
- Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™ • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Vivos Inc Updates Human Therapy Progress in India • GlobeNewswire Inc. • 02/03/2026 01:30:00 PM
- Vivos Inc. Strengthens Patent Protection with New U.S. Patent Issuance and PRECISIONGEL™ Trademark Approvals • GlobeNewswire Inc. • 01/28/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2026 04:06:21 PM
- Vivos Inc Summarizes Progress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 05:56:08 PM
- Vivos Inc Summarzes Preogress in its Animal Therapy Division • GlobeNewswire Inc. • 12/22/2025 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2025 12:34:42 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:08:03 AM
- Vivos Inc. Issues Shareholder Update Letter • GlobeNewswire Inc. • 11/06/2025 01:30:00 PM
- Vivos Inc. Strengthens Strategic Collaboration with Exubrion Therapeutics • GlobeNewswire Inc. • 10/29/2025 12:30:00 PM
- Vivos Inc. Retains Top FDA Regulatory Expert Dr. John J. Smith, M.D., J.D., to Support IDE Submission for RadioGel® • GlobeNewswire Inc. • 10/27/2025 12:30:00 PM
- Vivos Inc Board Authorizes Vivos Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 05:46:00 PM
- Vivos Inc Board Authorizes Vivios Inc to Establish a Corporate Entity in India • GlobeNewswire Inc. • 09/29/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2025 08:01:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 07:32:46 PM
